- Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy2022 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or - Refractory Ovarian Cancer2016 | First Faculty of Medicine
- Starší pacientka léčená afatinibem2016 | First Faculty of Medicine
- Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database2021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis2019 | Faculty of Medicine in Pilsen
- A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis2013 | Second Faculty of Medicine